Related references
Note: Only part of the references are listed.Role of response gene to complement 32 in diseases
Sonia I. Vlaicu et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2008)
FGF2 Translationally Induced by Hypoxia Is Involved in Negative and Positive Feedback Loops with HIF-1α
Caroline Conte et al.
PLOS ONE (2008)
Response gene to complement 32, a novel regulator for transforming growth factor-β-induced smooth muscle differentiation of neural crest cells
Fengmin Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Delta-like ligand 4 (DII4) is induced by VEGF as a negative regulator of angiogenic sprouting
I. B. Lobov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
RGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2/M arrest
K. Saigusa et al.
ONCOGENE (2007)
TSPY potentiates cell proliferation and tumorigenesis by promoting cell cycle progression in HeLa and NIH3T3 cells
Shane W. Oram et al.
BMC CANCER (2006)
Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity
HY Zeng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Antiangiogenesis in cancer therapy - endostatin and its mechanisms of action
J Folkman
EXPERIMENTAL CELL RESEARCH (2006)
Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene
C Barclay et al.
CLINICAL CANCER RESEARCH (2005)
Distinct gene expression patterns of peripheral blood cells in hyper-IgE syndrome
T Tanaka et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Corticosteroids inhibit cell death induced by doxorubicin in cardiomyocytes: Induction of antiapoptosis, antioxidant, and detoxification genes
QM Chen et al.
MOLECULAR PHARMACOLOGY (2005)
Overexpression of RGC-32 in colon cancer and other tumors
M Fosbrink et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2005)
Angiogenesis - Where do we stand now?
M Simons
CIRCULATION (2005)
Expression of angiogenesis factors in human umbilical vein endothelial cells and their regulation by PEDF
S Aparicio et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
IGF-I and FGF-2 coordinately enhance cyclin D1 and cyclin E-cdk2 association and activity to promote G1 progression in oligodendrocyte progenitor cells
TJ Frederick et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2004)
The role of fibroblast growth factors and their receptors in prostate cancer
B Kwabi-Addo et al.
ENDOCRINE-RELATED CANCER (2004)
Overexpression of RFT induces G1-S arrest and apoptosis via p53/p21Waf1 pathway in glioma cell
H Kano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2
RH Cao et al.
NATURE MEDICINE (2003)
Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF
GF Wu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase
T Badea et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth
D Lyden et al.
NATURE MEDICINE (2001)
C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
ACR Epstein et al.
CELL (2001)
Proliferation of intimal smooth muscle cells - Attenuation of basic fibroblast growth factor 2-stimulated proliferation is associated with increased expression of cell cycle inhibitors
NE Olson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
